(RTTNews) - Viatris (VTRS) announced the launch in Canada of Gen-Clozapine orally disintegrating tablets, providing a new treatment option for treatment-resistant schizophrenia patients. This marks ...
CAVHANZA™ (nilotinib) Orally Disintegrating Tablets: A New, FDA-approved Treatment Offering PPI and H2RA Flexibility for Ph+ CML Patients1 Cycle Pharmaceuticals (Cycle) announces the FDA approval of ...
(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to the ...
What Is It, and Why Does It Matter? Cavhanza (nilotinib) is a new FDA-approved orally disintegrating tablet (ODT) formulation of nilotinib, a prescription medicine used to treat a type of blood cancer ...
27don MSN
Definium shares soar after reporting positive phase 3 results for single-dose depression treatment
Definium Therapeutics Inc. DFTX shares are surging Monday after the company announced positive topline results from its Phase 3 Emerge study evaluating DT120 orally disintegrating tablet in adults ...
Please provide your email address to receive an email when new articles are posted on . MindMed will use Catalent’s Zydis orally disintegrating tablet technology for the development of MM-120, an ...
SOMERSET, N.J., Mar. 7, 2019 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer ...
Indian shares are set to open higher on Monday, tracking a global rally, while oil prices tumbled after U.S. President Donald Trump and Iran's deputy foreign minister said an initial deal had been ...
Cycle Pharmaceuticals (Cycle) announces the FDA approval of CAVHANZA (nilotinib) Orally Disintegrating Tablets. Launching soon, the CAVHANZA formulation is specifically designed to improve solubility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results